Floatz logo

Star0602

Vulvar Neoplasms

Marengo Therapeutics, Inc.Phase 1/2Active
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

3 Active assets in the Vulvar Neoplasms cohort.

Asset / SponsorPhaseRating
Nivolumab
Instituto do Cancer do Estado de São Paulo
Phase 2CCC
Ganciclovir
Gene Surgery LLC
Phase 1CC
Stimotimagene Copolymerplasmid
Gene Surgery LLC
Phase 1CC

Same molecule, other indications

Star0602 is also rated in:

breast cancerDormant
CCC
Indicative ·
48 / 100
View asset →
triple-negative breast carcinomaDormant
CCC
Indicative ·
48 / 100
View asset →
female reproductive system neoplasmDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →